 |
|
|
 |

Awareness Of Link Between Diabetes, Heart Disease And Stroke Critically Lacking
A new survey of people with diabetes reveals that 68 percent are not aware of their increased risk for
heart disease and stroke -- the leading cause of death in people with diabetes. People with diabetes are also unaware of ways
to reduce their risks for such serious complications, according to a survey commissioned by the American Diabetes Association
and the American College of Cardiology. more
|
 |
Mouse Model For Preeclampsia Discovered
Using new technology to monitor blood pressure, University of Iowa scientists and their colleagues
have discovered that a lab-bred mouse with borderline hypertension (high blood pressure) may be a very good model for
studying preeclampsia in women. more
|
|
|
 |
Working To Slow Enzyme That Eats Brain Proteins May One Day Lead To A Treatment For MS
Enzymes in the brain are not supposed to chew up proteins the way enzymes do in the digestive track.
However, the study of an unusual brain enzyme that may contribute to multiple sclerosis has started a Florida State University
chemist along a path that could one day lead to a treatment for MS, and promote healing of the damage it causes. more
|
 |
FDA Approves First Radiopharmaceutical Product To Treat Non-Hodgkin's Lymphoma
The FDA approved a novel treatment regime for one type of non-Hodgkins Lymphoma (NHL) that
for the first time includes a monoclonal antibody that is combined with a radioactive chemical. The product, Zevalin, must be
used along with Rituxan, an already approved biotechnology product for the disease -- low-grade B-cell NHL. It is approved
for patients who have not responded to standard chemotherapy treatments or to the use of Rituxan alone. more
|
 |
Dartmouth Researchers Expose Weakness of Common Toxoplasma gondii Parasite
Dartmouth Medical School geneticists in the Department of Microbiology and Immunology have
discovered how to weaken a common human parasite to prevent disease in an animal model after infection by the normal
parasite. The work, reported in the 21 February issue of Nature, opens new avenues for the development of vaccines and other
treatments for diseases such as toxoplasmosis caused by a diverse, but related group of protozoan parasites. more
|
|
|